Skip to main content

Specialty Pharmacy

  • Mylan sponsors Drug Store News and Pharmacist Society to provide a new business networking platform for pharmacy schools and students

    PITTSBURGH and NEW YORK — The Drug Store News Group, the Pharmacist Society and Mylan Inc., one of the world's leading generics and specialty pharmaceutical companies, are pleased to announce an exclusive sponsorship to expand membership opportunities at PharmacistSociety.com — an online forum that supports and enhances professional networks for U.S.-based retail pharmacists, professional organizations and pharmacy companies.

  • Sagent launches generic chemotherapy drug

    SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.

    Sagent announced the launch of irinotecan injection, a generic version of Pfizer's Camptosar, in latex-free, preservative-free, single-dose vials.

    Various versions of the drug had sales of about $28 million during the 12-month period ended in March, according to IMS Health.

  • Wolters Kluwer launches mobile app edition of Nursing Drug Handbook

    AMBLER, Pa. — Wolters Kluwer Health has introduced what it called the first mobile application for the Nursing Drug Handbook, the company said Thursday.

    Published by Lippincott Williams & Wilkins, the app is available for Apple and Android devices and is a mobile version of the popular reference for nurses that includes weekly updates.

  • Drug companies should meet payers' expectations of value, report finds

    NEW YORK — More than 80% of health plans would require a drug manufacturer to demonstrate a clear clinical benefit compared with current branded and generic treatments in order for its drug to be placed in the plan's formulary, according to a new survey.

  • Results from phase-3 trial of Pfizer cancer drug disappoint

    NEW YORK — An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

  • Reports: Legislation proposed for biosimilars, overseas drug manufacturers

    NEW YORK — Legislation proposed in the House of Representatives would speed up Food and Drug Administration approval of knock-off versions of vaccines and other biologics while requiring the agency to conduct more inspections of drug factories overseas, according to published reports.

    The Pittsburgh Post-Gazette reported that the bills, sponsored by Republican Rep. Tim Murphy of Pennsylvania, would create an expedited FDA approval pathway for follow-on versions of biogenetic medications such as vaccines and drugs made from human tissue and plasma.

  • Melanoma campaign enlists former football coach as spokesman

    NEW YORK — A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

    Former National Football League Pittsburgh Steelers coach Bill Cowher will work with Melanoma Exposed, an educational campaign run by the Melanoma International Foundation, Melanoma Research Alliance, Melanoma Research Foundation and the Skin Cancer Foundation, with sponsorship from drug maker Bristol-Myers Squibb, the organizations announced Tuesday.

  • Armada to move into expanded office space

    FLORHAM PARK, N.J. — Specialty pharmacy group purchasing and channel management organization Armada Health Care is moving into a bigger office space, the company said Tuesday.

    Armada announced that the new space, two floors up from its current offices at 100 Campus Drive in Florham Park, N.J., is nearly three times larger. The company plans to take possession of the new offices in late June and expects to use it to support its expanded service and technology divisions.

X
This ad will auto-close in 10 seconds